在牛皮关节炎中解码肝功能障碍的临床和分子途径:累积甲状腺剂量的影响
M Ruiz-Ponce1, L Cuesta-López1, M D López-Montilla1
1Rheumatology service/Department of Medical and Surgical Sciences, Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ /University of Cordoba/ Reina Sofia University Hospital, Córdoba, Spain.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|November 1, 2023
概括
牛皮关节炎 (PsA) 患者面临更高的肝脏疾病风险,受并发症和炎症的影响. 甲托雷克萨特剂量没有显示出临床肝脏影响,但新的疗法可能会减少与PsA相关的肝细胞损伤.
科学领域:
- 类风湿病学 类风湿病学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮关节炎 (PsA) 越来越多地与肝脏异常有关,特别是非酒精性脂肪性肝病 (NAFLD).
- 鉴定临床和分子因素对于检测高风险NAFLD的PsA患者至关重要.
- 了解这些因素可以指导早期干预和管理策略.
研究的目的:
- 用体外和体外模型研究PsA和甲状腺对肝功能的影响.
- 分析PsA,甲铁酸剂量和肝病风险之间的关系.
- 探索PsA相关的肝脏异常背后的分子机制.
主要方法:
- 在387名受试者 (200名PsA,87名NAFLD-非PsA,100名健康捐赠者) 的横截面研究中.
- 对83名PsA患者进行了回顾性纵向研究,这些患者接受了甲铁.
- 使用肝细胞细胞系 (HEPG2) 的体外实验和临床/实验室参数分析.
主要成果:
- 患有PsA的患者表现出肝病风险增加,与心脏代谢问题,炎症,乳头炎症和牛皮相关.
- 血清PSA诱导了肝细胞中的炎症,纤维化,细胞应激和亡反应.
- 甲托雷克萨特在分子水平上影响了肝脏生物学,但累积剂量与临床肝功能变化没有相关性.
结论:
- 肝病风险,并发症和PSA的疾病特征之间存在复杂的相互作用.
- 甲托雷克萨特剂量对PsA患者的肝脏参数没有显著影响,这得到了体外研究结果的支持.
- 抗PDE-4和抗JAK疗法显示出减轻PsA血清诱导的肝细胞激活的潜力.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
01:17Phase II Reactions: Methylation Reactions
203
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
203